Search research articles
Contact Us
Filters
Showing results (211-220 of 288) with videos related to
Page
of 29
Sort By:
Investigational New Drugs
|
February 26, 2014
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer
Alan L Ho, Brynna L Lipson, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
Antoine Desilets, Joris L Vos, Nora Katabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
David G Pfister, Yungpo Bernard Su, Dennis H Kraus, et al.
Head & Neck
|
August 14, 1998
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck
L B Harrison, A Raben, D G Pfister, et al.
Oral Oncology
|
September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Lara A Dunn, Alan L Ho, Loren S Michel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2008
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
Stephanie A Terezakis, Kyungmouk S Lee, Ronald A Ghossein, et al.
Journal of Pharmacology & Clinical Toxicology
|
December 27, 2024
A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 Biomarker
Lauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Cancer
|
October 27, 2020
Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities
Olga Strachna, Marc A Cohen, Monica M Allison, et al.
Cancer
|
January 23, 2014
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue
Neil M Iyengar, Amit Kochhar, Patrick G Morris, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 288) with videos related to
Sort By:
Page
of 29
Investigational New Drugs
|
February 26, 2014
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer
Alan L Ho, Brynna L Lipson, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
V A Miller, F M Benedetti, J R Rigas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
Antoine Desilets, Joris L Vos, Nora Katabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
David G Pfister, Yungpo Bernard Su, Dennis H Kraus, et al.
Head & Neck
|
August 14, 1998
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck
L B Harrison, A Raben, D G Pfister, et al.
Oral Oncology
|
September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Lara A Dunn, Alan L Ho, Loren S Michel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 5, 2008
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
Stephanie A Terezakis, Kyungmouk S Lee, Ronald A Ghossein, et al.
Journal of Pharmacology & Clinical Toxicology
|
December 27, 2024
A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 Biomarker
Lauren E Thompson, Avisek Ghimire, Xia Wen, et al.
Cancer
|
October 27, 2020
Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities
Olga Strachna, Marc A Cohen, Monica M Allison, et al.
Cancer
|
January 23, 2014
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue
Neil M Iyengar, Amit Kochhar, Patrick G Morris, et al.
Page
of 29